Available Courses

• DIABETES MANAGEMENT SYMPOSIUM & CERTIFICATION WORKSHOP

  DIABETES MANAGEMENT SYMPOSIUM
  & CERTIFICATION WORKSHOP
  
  OBJECTIVES
  Health care providers who complete this activity should be to: 1. Identify the classes of medications that can used to slow diabetic nephropathy. 2. Describe focal diabetic neuropathy. 3. Discuss the connection between erectile dysfunction and diabetes. 4. Diagnose gestational diabetes mellitus
  
  CONTINUING MEDICAL EDUCATION CREDIT
  The National Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  The National Medical Association Medical Association designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  The National Medical Association has been reviewed and approved as an Authorized Provider by the International Association for Continuing Medical Education and Training (IACET), 8405 Greensboro Drive, Suite 800, McLean, VA 22102-5120. The National Medical Association has awarded 0.1 of CEUs to participants who successfully complete this program.
  Participants must achieve a post test score of 80% or higher to obtain credit.
  DISCLAIMER
  The National Medical Association and its staff are not responsible for injury or illness resulting from the use of medications or modalities discussed during this educational activity.
• Diabetes 09

    

  Intended Audience: This program is intended for primary care and family medicine
  physicians, internists, nurse practitioners and other healthcare professionals interested in diabetes.
  
  Objectives
  Following participation in this session, attendees should be able
  to: 1) understand the supportive evidence for diabetes care provided
  in the national practice guidelines, 2) evaluate relevant multiple
  mechanisms that progress to Type 2 diabetes, and 3) discuss
  solutions and challenges that impact the multidisciplinary
  team providing diabetes.
  
  
• Dementia 09

  
  

  Intended Audience
  This program is intended for primary care and family medicine physicians, internists, geriatricians, nurse practitioners and other healthcare professionals interested in dementia.
  
  Objectives
  After participation in this session, attendees will be able to: 1) recognize Alzheimer’s disease in minority patients, 2) discuss office evaluation and management of dementia, and 3) utilize culturally competent treatment strategies throughout different stages of AD, and provide support for the caregivers of minority patients with dementia.
• Asthma/COPD Session

  Emergency Medicine - Asthma / COPD
  

  • I’ll Huff and I’ll Puff…Acute Management of the COPD Patient
  • Acute Asthma: Pitfalls, Controversies and Mortalities in the Emergency Department
• “Disparities and Cardiovascular Risk Stratification in Minority Populations —Working Towards Cross-Cultural Competency”

  Disparities and Cardiovascular Risk Stratification in Minority
  Populations – Working Toward Cross-Cultural Competency
  A Quality Improvement Initiative
  
  Learning Objectives
  Upon completion of this activity, participants should be able to:
  

  1. Identify differences in prevalence of cardiovascular risk factors and hypertension control rates between different racial and ethnic groups.
  2. Understand risk stratification and goals of therapy in patients with cardiovascular risk factors.
  3. Compare and contrast the efficacy and safety of common multi-drug anti-hypertension therapies to select appropriate regimens for individual patients.
  4. Understand the importance and potential causes of health care disparities in the U.S.
  5. Apply the ESFT (Explanatory/Social/Fears/Treatment) model to address barriers to adherence and improve communication in diverse populations.
• Atherothrombotic Diseases-Epidemiology, Prevention and Treatment

    

  Continuing Medical Education: The National Medical
  Association is accredited by the Accreditation Council for
  Continuing Medical Education to provide continuing
  medical education for physicians.
  The National Medical Association designates
  this continuing medical education activity for
  a maximum of 26.25 AMA PRA Category 1
  Credits™. Physicians should only claim credit commensurate
  with the extent of their participation in the activity.
  The National Medical Association CME Activity “Internal
  Medicine Seminar” of the National Medical Association
  has been reviewed and approved as an Authorized
  Provider by the International Association for Continuing
  Education and Training (IACET), 1620 I Street, NW,
  Suite 615, Washington, DC 20006. The National Medical
  Association has awarded 2.6 of CEU’s to participants who
  successfully complete this program.
  Statement of Disclosure: Faculty for the National Medical
  Association programs are expected to disclose at the
  beginning of their educational presentation any relevant
  financial relationships with the commercial company.
  
  Disclaimer: The National Medical Association (NMA)
  and its staff are not responsible for injury or illness resulting
  from the use of medications or modalities discussed
  during this educational activity. The NMA does not
  endorse the use of off-labeled medications.
• 2008 ANNUAL CONVENTION: PSYCHIATRY AND THE BEHAVIORAL SCIENCES SECTION

  
  

  
  

  Overall Objectives:
  At the completion this educational activity, the attendee should be able to: 1) recognize the benefits of using the new generation mental health medications to treat African American and other disparate patient populations; 2) understand the relevant drug metabolism interactions inherent in treating African American patients with atypical agents used for treating mental illnesses; 3) utilize the needed clinical strategies to address medically co-morbid conditions within a psychiatric practice; 4) identify the best-practice models/techniques for the diagnosis and evidence-based treatment of African American, other ethnic minority and priority patient populations; and 5) apply diagnostic and screening techniques/tools.